COG-UK Consortium
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
COG-UK Consortium; Volz, E; Hill, V; McCrone, JT; Price, A; Jorgensen, D; O'Toole, A; Southgate, J; Johnson, R; Jackson, B; Nascimento, FF; Rey, SM; Nicholls, SM; Colquhoun, RM; Filipe, AD; Shepherd, J; Pascall, DJ; Shah, R; Jesudason, N; Li, K; Jarrett, R; Pacchiarini, N; Bull, M; Geidelberg, L; Siveroni, I; Goodfellow, I; Loman, NJ; Pybus, OG; Robertson, DL; Thomson, EC; Rambaut, A; Connor, TR
Authors
E Volz
V Hill
JT McCrone
A Price
D Jorgensen
A O'Toole
J Southgate
R Johnson
B Jackson
FF Nascimento
SM Rey
SM Nicholls
RM Colquhoun
AD Filipe
J Shepherd
DJ Pascall
R Shah
N Jesudason
K Li
R Jarrett
N Pacchiarini
M Bull
L Geidelberg
I Siveroni
I Goodfellow
NJ Loman
OG Pybus
DL Robertson
EC Thomson
A Rambaut
TR Connor
Abstract
Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G are suggestive of a selective advantage but may also be due to a random founder effect. We investigate the hypothesis for positive selection of spike D614G in the United Kingdom using more than 25,000 whole genome SARS-CoV-2 sequences. Despite the availability of a large dataset, well represented by both spike 614 variants, not all approaches showed a conclusive signal of positive selection. Population genetic analysis indicates that 614G increases in frequency relative to 614D in a manner consistent with a selective advantage. We do not find any indication that patients infected with the spike 614G variant have higher COVID-19 mortality or clinical severity, but 614G is associated with higher viral load and younger age of patients. Significant differences in growth and size of 614G phylogenetic clusters indicate a need for continued study of this variant.
Citation
COG-UK Consortium, Volz, E., Hill, V., McCrone, J., Price, A., Jorgensen, D., …Connor, T. (2021). Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity. Cell, 184(1), 64-+. https://doi.org/10.1016/j.cell.2020.11.020
Journal Article Type | Article |
---|---|
Acceptance Date | Nov 11, 2020 |
Publication Date | 2021 |
Deposit Date | Jan 12, 2022 |
Publicly Available Date | Jan 12, 2022 |
Print ISSN | 0092-8674 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 184 |
Issue | 1 |
Pages | 64-+ |
DOI | https://doi.org/10.1016/j.cell.2020.11.020 |
Keywords | RESPIRATORY SYNDROME CORONAVIRUS; ACTIVATION; APE |
Public URL | https://rvc-repository.worktribe.com/output/1555268 |
Files
OA
(3.9 Mb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Downloadable Citations
About RVC Repository
Administrator e-mail: publicationsrepos@rvc.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search